Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein

Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy

(2019) Balvindar Singh et al.   ACTA NEUROPATHOLOGICA

A Longitudinal Study of Epileptic Seizures in Alzheimer's Disease

(2019) John Baker et al.   Frontiers in Neurology

Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein

(2018) Kimberly A. McDowell et al.   Journal of Parkinsons Disease

A53T mutant alpha-synuclein induces tau dependent postsynaptic impairment independent of neurodegenerative changes

(2018) Peter J. Teravskis et al.   JOURNAL OF NEUROSCIENCE

Relative Incidence of Seizures and Myoclonus in Alzheimer’s Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia

(2017) Alexander J. Beagle et al.   JOURNAL OF ALZHEIMERS DISEASE

Suppression of interictal spikes during phasic rapid eye movement sleep: a quantitative stereo-electroencephalography study

(2017) C. Campana et al.   JOURNAL OF SLEEP RESEARCH

Epileptic activity in Alzheimer's disease: causes and clinical relevance

(2017) Keith A Vossel et al.   LANCET NEUROLOGY

Incidence and impact of subclinical epileptiform activity in Alzheimer's disease

(2016) Keith A. Vossel et al.   ANNALS OF NEUROLOGY

EEG desynchronization during phasic REM sleep suppresses interictal epileptic activity in humans

(2016) Birgit Frauscher et al.   EPILEPSIA

Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology

(2016) Korey Kam et al.   Scientific Reports

GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein

(2014) J J Credle et al.   CELL DEATH AND DIFFERENTIATION

Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits

(2014) Eric C. Miller et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

(2013) Silke Appel-Cresswell et al.   MOVEMENT DISORDERS

Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease

(2013) Keith A. Vossel et al.   JAMA Neurology

Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases

(2012) Sarah M. Rothman et al.   NEUROMOLECULAR MEDICINE

Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony

(2012) C. Sales-Carbonell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model

(2012) P. E. Sanchez et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impaired GABA and Glycine Transmission Triggers Cardinal Features of Rapid Eye Movement Sleep Behavior Disorder in Mice

(2011) P. L. Brooks et al.   JOURNAL OF NEUROSCIENCE

Amyloid- /Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

(2011) E. D. Roberson et al.   JOURNAL OF NEUROSCIENCE

Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

(2011) Jonathan Wills et al.   PLoS One

Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models

(2010) Lars M. Ittner et al.   CELL

Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior

(2010) Dianca R. Graham et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration

(2010) Brian R. Hoover et al.   NEURON

Genomic investigation of α-synuclein multiplication and parkinsonism

(2008) Owen A. Ross et al.   ANNALS OF NEUROLOGY

EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up

(2008) L. Bonanni et al.   BRAIN

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

(2008) Erik Stomrud et al.   NEUROBIOLOGY OF AGING